<html>
  <head>
    <title>
      Current Report
</title><!-- Licensed to: Gotham Filing Systems-->
<!-- Document Created using EDGARIZER HTML 3.0.0.39895 -->
<!-- Copyright 2005 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff"><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><strong>UNITED
      STATES</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><strong>SECURITIES
      AND EXCHANGE COMMISSION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><strong>Washington,
      DC 20549</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman"><strong>FORM
      8-K</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><strong>CURRENT
      REPORT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pursuant
      to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Date
      of Report (Date of earliest event reported): July 13, 2005</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 24pt; FONT-FAMILY: Times New Roman"><strong>Xenomics,
      Inc.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(Exact
      name of registrant as specified in its charter)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div align="center">
      <table bgcolor="#ffffff" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="#ffffff">
            <td width="5%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
            <td colspan="2" width="31%" style="BORDER-BOTTOM: #000000 thin solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Florida</font></div>
            </td>
            <td width="28%" style="BORDER-BOTTOM: #ffffff solid">
            </td>
            <td colspan="2" width="31%" style="BORDER-BOTTOM: #000000 thin solid">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">04-3721895</font></div>
            </td>
            <td width="5%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
          </tr>
          <tr bgcolor="#ffffff">
            <td width="5%">&#160;</td>
            <td colspan="2" width="31%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(State
                or other jurisdiction of</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">incorporation
                or organization)</font></div>
            </td>
            <td width="28%">
            </td>
            <td colspan="2" valign="top" width="31%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(IRS
                Employer <font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Identification
                No.)</font></font></div>
            </td>
            <td width="5%">&#160;</td>
          </tr>
          <tr bgcolor="#ffffff">
            <td width="5%">&#160;</td>
            <td width="25%">&#160;</td>
            <td width="6%">&#160;</td>
            <td width="28%">
            </td>
            <td width="6%">
            </td>
            <td width="25%">&#160;</td>
            <td width="5%">&#160;</td>
          </tr>
          <tr bgcolor="#ffffff">
            <td width="5%">&#160;</td>
            <td width="25%">&#160;</td>
            <td colspan="3" width="40%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">420
                Lexington Avenue, Suite 1701</font></div>
            </td>
            <td width="25%">&#160;</td>
            <td width="5%">&#160;</td>
          </tr>
          <tr bgcolor="#ffffff">
            <td width="5%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
            <td width="25%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
            <td colspan="3" width="40%" style="BORDER-BOTTOM: #000000 thin solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">New
                York, New York&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                10170</font></div>
            </td>
            <td width="25%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
            <td width="5%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
          </tr>
          <tr bgcolor="#ffffff">
            <td width="5%">&#160;</td>
            <td width="25%">&#160;</td>
            <td colspan="3" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(Address
                of principal executive offices)</font></div>
            </td>
            <td width="25%">&#160;</td>
            <td width="5%">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Registrant&#8217;s
      telephone number, including area code: (212) 297-0808</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(Former
      name or former address, if changed since last report)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Check
      the appropriate box below if the Form 8-K filing is intended to simultaneously
      satisfy the filing obligation of the registrant under any of the following
      provisions:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font></div>
            </td>
            <td align="left" valign="top" width="91%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Written
                communication pursuant to Rule 425 under the Securities Act (17 CFR
                230.425)</font></div>
            </td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%">&#160;</td>
            <td align="left" valign="top" width="91%">&#160;</td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font></div>
              </div>
            </td>
            <td align="left" valign="top" width="91%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Soliciting
                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
                240.14a-12)</font></div>
            </td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%">&#160;</td>
            <td align="left" valign="top" width="91%">&#160;</td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font></div>
              </div>
            </td>
            <td align="left" valign="top" width="91%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pre-commencement
                communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                CFR
                240.14d-2(b))</font></div>
            </td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%">&#160;</td>
            <td align="left" valign="top" width="91%">&#160;</td>
          </tr>
          <tr>
            <td width="6%">&#160;</td>
            <td align="left" valign="top" width="3%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font></div>
              </div>
            </td>
            <td align="left" valign="top" width="91%" style="BORDER-BOTTOM: medium none">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pre-commencement
                communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                CFR
                240.13e-4(c))</font></div>
            </td>
          </tr>

      </table>
    </div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><strong>Item
      1.01&#160;&#160;&#160;&#160;&#160;&#160;&#160; </strong></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><strong>Entry
      into a Material Definitive Agreement.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt">
        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The
              information required to be disclosed in this Item 1.01 is incorporated
              herein by
              reference from Item 3.02.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><strong>Item
              3.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><strong>Unregistered
              Sales of Equity Securities.</strong></font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On
              July
              13, 2005, Xenomics, Inc. (the &#8220;Company&#8221;) closed a private placement of 277,100
              shares of Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;)
              and 386,651 warrants to certain investors (the &#8220;Investors&#8221;) for aggregate gross
              proceeds of $2,771,000 pursuant to a Securities Purchase Agreement
              dated as of
              July 13, 2005 (the &#8220;SPA&#8221;). The warrants are immediately exercisable at $3.25 per
              share and are exercisable at any time within five years from the date
              of
              issuance. Pursuant to the SPA, the Company agreed that until January
              9, 2006,
              the Investors would have the right to participate in subsequent financings
              up to
              the lesser of $2,771,000 and the full amount of such subsequent financing.
              In
              addition, the Company agreed not to offer any of its securities for
              sale prior
              to the effectiveness date of its registration statement registering
              the
              securities purchased by the Investors (the &#8220;Registration Statement&#8221;), and the
              Company agreed not to file a registration statement seeking to register
              additional shares of common stock for resale until 180 days after the
              effectiveness date of the Registration Statement.&#160;The Company
              paid an
              aggregate $277,100 and issued an aggregate 105,432 warrants to purchase
              common
              stock to certain selling agents. The warrants are immediately exercisable
              at
              $3.25 per share and will expire five years after issuance. </font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In
              connection with the offer and sale of securities to the Investors and
              the
              selling agents, the Company relied on the exemption from registration
              provided
              by Section 4(2) of the Securities Act of 1933, as amended (the &#8220;Securities
              Act&#8221;), and Rule 506 promulgated thereunder. The Company believes that the
              Investors and the selling agents are &#8220;accredited investors&#8221;, as such term is
              defined in Rule 501(a) promulgated under the Securities Act. </font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#160;
              </font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The
              Investors also are parties to a Registration Rights Agreement, dated
              as of July
              13, 2005 (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company
              has agreed to file, within 30 days of closing, a registration statement
              covering
              the resale of the shares of common stock underlying the Series A Preferred
              Stock
              and Warrants issued to the Investors. </font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><strong>Item
              5.03&#160;&#160;&#160;&#160;&#160;&#160;&#160; </strong></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><strong>Amendments
              to Articles of Incorporation or Bylaws; Change in Fiscal
              Year.</strong></font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The
              Company&#8217;s</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman">
              Articles of Incorporation have been amended to provide for the issuance
              of
              277,100 shares of Series A Preferred Stock pursuant to the Articles
              of Amendment
              to the Articles of Incorporation filed with the State of Florida on
              July 13,
              2005, which provides that:</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><u>Dividends</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman">.
              </font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Holders
              shall be entitled to receive and the Company shall pay, cumulative
              dividends at
              the rate per share (as a percentage of the Stated Value per share of
              $10) of 4%
              per annum, payable quarterly on March 31, June 30, September 30 and
              December 31,
              beginning with September 30, 2005. If funds are legally available for
              the
              payment of dividends, dividends shall be payable, at the sole election
              of the
              Company, in cash or shares of Common Stock which shall be valued solely
              for such
              purpose at 90% of the average of the volume weighted average price
              for the 20
              days immediately prior to the Dividend Payment Date. If funds are not
              legally
              available for the payment of dividends then, at the election of such
              Holder,
              such dividends shall accrue to the next Dividend Payment Date or shall
              be
              accreted to the outstanding Stated Value. If at any time the Company
              has the
              right to pay dividends in cash or Common Stock, the Company must provide
              the
              Holder with at least 20 Trading Days&#8217; notice of its election to pay a regularly
              scheduled dividend in Common Stock. Dividends on the Series A Preferred
              Stock
              shall be calculated on the basis of a 360-day year, shall accrue daily
              commencing on July 13, 2005, and shall be deemed to accrue from such
              date
              whether or not earned or declared and whether or not there are profits,
              surplus
              or other funds of the Company legally available for the payment of
              dividends.
              Notwithstanding the foregoing, the Company shall only be permitted
              to make a
              dividend payment in Common Stock provided that such shares of Common
              Stock have
              been registered under the Securities Act.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="2">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><u>Voting
              Rights.</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Except
              as
              otherwise provided herein and as otherwise required by law, the Series
              A
              Preferred Stock shall have no voting rights. However, so long as any
              shares of
              Series A Preferred Stock are outstanding, the Company shall not, without
              the
              affirmative vote of the Holders of the shares of the Series A Preferred
              Stock
              then outstanding, (a) alter or change adversely the powers, preferences
              or
              rights given to the Series A Preferred Stock or alter or amend these
              Articles of
              Amendment (whether by merger, consolidation or otherwise), (b) authorize
              or
              create any class of stock ranking as to dividends, redemption or distribution
              of
              assets upon a Liquidation senior to or otherwise pari passu with the
              Series A
              Preferred Stock, (c) amend its certificate of incorporation or other
              charter
              documents (whether by merger, consolidation or otherwise) so as to
              affect
              adversely any rights of the Holders, (d) increase the authorized number
              of
              shares of Series A Preferred Stock, or (e) enter into any agreement
              with respect
              to the foregoing.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Liquidation</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">.
              Upon
              any liquidation, dissolution or winding-up of the Company, whether
              voluntary or
              involuntary (a &#8220;Liquidation&#8221;), the Holders shall be entitled to receive out of
              the assets of the Company, whether such assets are capital or surplus,
              for each
              share of Series A Preferred Stock an amount equal to the Stated Value
              per share
              plus any accrued and unpaid dividends thereon and any other fees or
              liquidated
              damages owing thereon before any distribution or payment shall be made
              to the
              holders of any junior securities, and if the assets of the Company
              shall be
              insufficient to pay in full such amounts, then the entire assets to
              be
              distributed to the Holders shall be distributed among the Holders ratably
              in
              accordance with the respective amounts that would be payable on such
              shares if
              all amounts payable thereon were paid in full.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Conversion</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Conversions
              at Option of Holder</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">.
              Each
              share of Series A Preferred Stock shall be convertible into that number
              of
              shares of Common Stock determined by dividing the Stated Value of such
              share of
              Series A Preferred Stock by $2.15 (the &#8220;Conversion Price&#8221;), at the option of the
              Holder, at any time and from time to time from and after July 13,
              2005.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Automatic
              Conversion</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">.
              Beginning July 13, 2006, provided certain conditions are satisfied,
              if the
              volume weighted average price of the Common Stock equals $4.30 (subject
              to
              adjustment for stock splits, reclassifications, combinations and similar
              adjustments) per share for the 20 consecutive Trading Days immediately
              prior to
              the Automatic Conversion Notice Date (as defined below), and an average
              of
              50,000 shares of Common Stock per day shall have been traded during
              such 20
              Trading Days, unless the Holder is prohibited from converting the Series
              A
              Preferred Stock pursuant to certain limitations, the Company shall
              have the
              right to deliver a notice to the Holder (an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Automatic
              Conversion Notice</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8221;
              and the
              date such notice is received by the Holder, the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Automatic
              Conversion Notice Date</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8221;),
              to
              convert any portion of the shares of Series A Preferred Stock then
              held by the
              Holder into shares of Common Stock at the then-effective Conversion
              Price.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Subsequent
              Equity Sales</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">.
              Other
              than pursuant to certain issuances, for the twelve (12) month period
              beginning
              on the effective date of the Registration Statement registering the
              resale of
              the shares of Common Stock underlying the Series A Preferred Stock
              by the
              Holder, if the Company at any time while Series A Preferred Stock is
              outstanding, shall sell or grant any option to purchase or otherwise
              dispose of
              or issue any Common Stock or common stock equivalents entitling any
              Person to
              acquire shares of Common Stock, at an effective price per share less
              than the
              then Conversion Price (such lower price, the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Base
              Conversion Price</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8221;
              and
              such issuances individually and collectively, a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><u>Dilutive
              Issuance</u></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8221;),
              as
              adjusted hereunder (if the holder of the Common Stock or common stock
              equivalents so issued shall at any time, whether by operation of</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="2">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">purchase
              price adjustments, reset provisions, floating conversion, exercise
              or exchange
              prices or otherwise, or due to warrants, options or rights per share
              which is
              issued in connection with such issuance, be entitled to receive shares
              of Common
              Stock at an effective price per share which is less than the Conversion
              Price,
              such issuance shall be deemed to have occurred for less than the Conversion
              Price), then, the Conversion Price shall be reduced by multiplying
              the
              Conversion Price by a fraction, the numerator of which is the number
              of shares
              of Common Stock issued and outstanding immediately prior to the Dilutive
              Issuance plus the number of shares of Common Stock and common stock
              equivalents
              which the aggregate consideration received or receivable by the Company
              in
              connection with such Dilutive Issuance would purchase at the then effective
              Conversion Price, and the denominator of which shall be the sum of
              the number of
              shares of Common Stock issued and outstanding immediately prior to
              the Dilutive
              Issuance plus the number of shares of Common Stock and common stock
              equivalents
              so issued or assumable in connection with the Dilutive Issuance. </font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; COLOR: #000000; FONT-FAMILY: Times New Roman">A
              copy of the Articles of Amendment to the Articles of Incorporation,
              as filed
              with the Secretary of State of the State of Florida, is attached as
              Exhibit 3.1
              to this Current Report on Form 8-K, and is incorporated herein by reference.
              </font></div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, serif"><strong>Item
            9.01&#160;&#160;&#160;&#160;&#160;&#160;&#160; </strong></font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, serif"><strong>Financial
            Statements and Exhibits</strong></font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td width="5%">&#160;</td>
              <td width="3%">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, serif">(c)</font></div>
              </td>
              <td align="left" colspan="2" valign="top" width="92%">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, serif">Exhibits.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%">&#160;</td>
              <td width="3%">&#160;</td>
              <td align="left" valign="top" width="5%">&#160;</td>
              <td align="left" valign="top" width="87%">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">3.1</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Articles
                  of Amendment to Articles of Incorporation of Xenomics,
                  Inc.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">4.1</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Form
                  of Warrant to purchase shares of Common Stock issued in connection
                  with
                  the sale of the Series A Convertible Preferred Stock.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">4.2</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Form
                  of Warrant to purchase shares of Common Stock issued to selling
                  agents in
                  connection with the sale of the Series A Convertible Preferred
                  Stock.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">10.1</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Form
                  of Securities Purchase Agreement dated July 13, 2005 by and among
                  Xenomics, Inc. and the purchasers set forth on the signature page
                  thereto.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">10.2</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Form
                  of Registration Rights Agreement dated July 13, 2005 by and among
                  Xenomics, Inc. and the purchasers signatory thereto.</font></div>
              </td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">&#160;</td>
            </tr>
            <tr>
              <td width="5%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td width="3%" style="BORDER-BOTTOM: medium none">&#160;</td>
              <td align="left" valign="top" width="5%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">99.1</font></div>
              </td>
              <td align="left" valign="top" width="87%" style="BORDER-BOTTOM: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Press
                  Release dated July 15, 2005.</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><strong>SIGNATURE</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pursuant
      to the requirements of the Securities Exchange Act of 1934, the Registrant
      has
      duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Dated:</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">July
      19, 2005</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <table align="center" bgcolor="#ffffff" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr valign="top" bgcolor="#ffffff">
            <td width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;</font></td>
            <td width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;</font></td>
            <td width="49%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;</font></td>
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">XENOMICS,
              INC.</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;<br>&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td>&#160;</td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">By:&#160;&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">/s/
              V. Randy White</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="FONT-FAMILY: Times New Roman, serif" size="1">&#160;</font></td>
            <td align="left">
              <hr style="COLOR: #000000" align="left" noshade size="2" width="80%">
            </td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">&#160;</font></td>
            <td>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">V.
                Randy White, Ph.D.</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Chief
                Executive Officer</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
      <div>
        <hr style="COLOR: #000000" align="left" noshade size="2" width="100%">
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 198pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
  </body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "form8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 54889}]
{"company-data": {"conformed-name": "XENOMICS INC", "cik": "0001213037", "assigned-sic": "7389", "irs-number": "043721895", "state-of-incorporation": "FL", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-103083", "film-number": "05961554"}, "business-address": {"street1": "420 LEXINGTON AVENUE SUITE 1701", "city": "NEW YORK", "state": "NY", "zip": "10170", "phone": "732-438-8290"}, "mail-address": {"street1": "420 LEXINGTON AVENUE SUITE 1701", "city": "NEW YORK", "state": "NY", "zip": "10170"}, "former-company": {"former-conformed-name": "USED KAR PARTS INC", "date-changed": "20030106"}}
Current Report
UNITED
      STATES
SECURITIES
      AND EXCHANGE COMMISSION
Washington,
      DC 20549
FORM
      8-K
CURRENT
      REPORT
Pursuant
      to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
      of Report (Date of earliest event reported): July 13, 2005
Xenomics,
      Inc.
(Exact
      name of registrant as specified in its charter)
Florida
04-3721895
(State
                or other jurisdiction of
incorporation
                or organization)
(IRS
                Employer
Identification
                No.)
420
                Lexington Avenue, Suite 1701
New
                York, New York         
                10170
(Address
                of principal executive offices)
Registrant's
      telephone number, including area code: (212) 297-0808
(Former
      name or former address, if changed since last report)
Check
      the appropriate box below if the Form 8-K filing is intended to simultaneously
      satisfy the filing obligation of the registrant under any of the following
      provisions:
o
Written
                communication pursuant to Rule 425 under the Securities Act (17 CFR
                230.425)
o
Soliciting
                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
                240.14a-12)
o
Pre-commencement
                communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                CFR
                240.14d-2(b))
o
Pre-commencement
                communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                CFR
                240.13e-4(c))
Item
      1.01
Entry
      into a Material Definitive Agreement.
The
              information required to be disclosed in this Item 1.01 is incorporated
              herein by
              reference from Item 3.02.
Item
              3.02
Unregistered
              Sales of Equity Securities.
On
              July
              13, 2005, Xenomics, Inc. (the "Company") closed a private placement of 277,100
              shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock")
              and 386,651 warrants to certain investors (the "Investors") for aggregate gross
              proceeds of $2,771,000 pursuant to a Securities Purchase Agreement
              dated as of
              July 13, 2005 (the "SPA"). The warrants are immediately exercisable at $3.25 per
              share and are exercisable at any time within five years from the date
              of
              issuance. Pursuant to the SPA, the Company agreed that until January
              9, 2006,
              the Investors would have the right to participate in subsequent financings
              up to
              the lesser of $2,771,000 and the full amount of such subsequent financing.
              In
              addition, the Company agreed not to offer any of its securities for
              sale prior
              to the effectiveness date of its registration statement registering
              the
              securities purchased by the Investors (the "Registration Statement"), and the
              Company agreed not to file a registration statement seeking to register
              additional shares of common stock for resale until 180 days after the
              effectiveness date of the Registration Statement. The Company
              paid an
              aggregate $277,100 and issued an aggregate 105,432 warrants to purchase
              common
              stock to certain selling agents. The warrants are immediately exercisable
              at
              $3.25 per share and will expire five years after issuance.
In
              connection with the offer and sale of securities to the Investors and
              the
              selling agents, the Company relied on the exemption from registration
              provided
              by Section 4(2) of the Securities Act of 1933, as amended (the "Securities
              Act"), and Rule 506 promulgated thereunder. The Company believes that the
              Investors and the selling agents are "accredited investors", as such term is
              defined in Rule 501(a) promulgated under the Securities Act.
The
              Investors also are parties to a Registration Rights Agreement, dated
              as of July
              13, 2005 (the "Registration Rights Agreement"), pursuant to which the Company
              has agreed to file, within 30 days of closing, a registration statement
              covering
              the resale of the shares of common stock underlying the Series A Preferred
              Stock
              and Warrants issued to the Investors.
Item
              5.03
Amendments
              to Articles of Incorporation or Bylaws; Change in Fiscal
              Year.
The
              Company's
Articles of Incorporation have been amended to provide for the issuance
              of
              277,100 shares of Series A Preferred Stock pursuant to the Articles
              of Amendment
              to the Articles of Incorporation filed with the State of Florida on
              July 13,
              2005, which provides that:
Dividends
.
Holders
              shall be entitled to receive and the Company shall pay, cumulative
              dividends at
              the rate per share (as a percentage of the Stated Value per share of
              $10) of 4%
              per annum, payable quarterly on March 31, June 30, September 30 and
              December 31,
              beginning with September 30, 2005. If funds are legally available for
              the
              payment of dividends, dividends shall be payable, at the sole election
              of the
              Company, in cash or shares of Common Stock which shall be valued solely
              for such
              purpose at 90% of the average of the volume weighted average price
              for the 20
              days immediately prior to the Dividend Payment Date. If funds are not
              legally
              available for the payment of dividends then, at the election of such
              Holder,
              such dividends shall accrue to the next Dividend Payment Date or shall
              be
              accreted to the outstanding Stated Value. If at any time the Company
              has the
              right to pay dividends in cash or Common Stock, the Company must provide
              the
              Holder with at least 20 Trading Days' notice of its election to pay a regularly
              scheduled dividend in Common Stock. Dividends on the Series A Preferred
              Stock
              shall be calculated on the basis of a 360-day year, shall accrue daily
              commencing on July 13, 2005, and shall be deemed to accrue from such
              date
              whether or not earned or declared and whether or not there are profits,
              surplus
              or other funds of the Company legally available for the payment of
              dividends.
              Notwithstanding the foregoing, the Company shall only be permitted
              to make a
              dividend payment in Common Stock provided that such shares of Common
              Stock have
              been registered under the Securities Act.
2
Voting
              Rights.
Except
              as
              otherwise provided herein and as otherwise required by law, the Series
              A
              Preferred Stock shall have no voting rights. However, so long as any
              shares of
              Series A Preferred Stock are outstanding, the Company shall not, without
              the
              affirmative vote of the Holders of the shares of the Series A Preferred
              Stock
              then outstanding, (a) alter or change adversely the powers, preferences
              or
              rights given to the Series A Preferred Stock or alter or amend these
              Articles of
              Amendment (whether by merger, consolidation or otherwise), (b) authorize
              or
              create any class of stock ranking as to dividends, redemption or distribution
              of
              assets upon a Liquidation senior to or otherwise pari passu with the
              Series A
              Preferred Stock, (c) amend its certificate of incorporation or other
              charter
              documents (whether by merger, consolidation or otherwise) so as to
              affect
              adversely any rights of the Holders, (d) increase the authorized number
              of
              shares of Series A Preferred Stock, or (e) enter into any agreement
              with respect
              to the foregoing.
Liquidation
.
              Upon
              any liquidation, dissolution or winding-up of the Company, whether
              voluntary or
              involuntary (a "Liquidation"), the Holders shall be entitled to receive out of
              the assets of the Company, whether such assets are capital or surplus,
              for each
              share of Series A Preferred Stock an amount equal to the Stated Value
              per share
              plus any accrued and unpaid dividends thereon and any other fees or
              liquidated
              damages owing thereon before any distribution or payment shall be made
              to the
              holders of any junior securities, and if the assets of the Company
              shall be
              insufficient to pay in full such amounts, then the entire assets to
              be
              distributed to the Holders shall be distributed among the Holders ratably
              in
              accordance with the respective amounts that would be payable on such
              shares if
              all amounts payable thereon were paid in full.
Conversion
.
Conversions
              at Option of Holder
.
              Each
              share of Series A Preferred Stock shall be convertible into that number
              of
              shares of Common Stock determined by dividing the Stated Value of such
              share of
              Series A Preferred Stock by $2.15 (the "Conversion Price"), at the option of the
              Holder, at any time and from time to time from and after July 13,
              2005.
Automatic
              Conversion
.
              Beginning July 13, 2006, provided certain conditions are satisfied,
              if the
              volume weighted average price of the Common Stock equals $4.30 (subject
              to
              adjustment for stock splits, reclassifications, combinations and similar
              adjustments) per share for the 20 consecutive Trading Days immediately
              prior to
              the Automatic Conversion Notice Date (as defined below), and an average
              of
              50,000 shares of Common Stock per day shall have been traded during
              such 20
              Trading Days, unless the Holder is prohibited from converting the Series
              A
              Preferred Stock pursuant to certain limitations, the Company shall
              have the
              right to deliver a notice to the Holder (an "
Automatic
              Conversion Notice
"
              and the
              date such notice is received by the Holder, the "
Automatic
              Conversion Notice Date
"),
              to
              convert any portion of the shares of Series A Preferred Stock then
              held by the
              Holder into shares of Common Stock at the then-effective Conversion
              Price.
Subsequent
              Equity Sales
.
              Other
              than pursuant to certain issuances, for the twelve (12) month period
              beginning
              on the effective date of the Registration Statement registering the
              resale of
              the shares of Common Stock underlying the Series A Preferred Stock
              by the
              Holder, if the Company at any time while Series A Preferred Stock is
              outstanding, shall sell or grant any option to purchase or otherwise
              dispose of
              or issue any Common Stock or common stock equivalents entitling any
              Person to
              acquire shares of Common Stock, at an effective price per share less
              than the
              then Conversion Price (such lower price, the "
Base
              Conversion Price
"
              and
              such issuances individually and collectively, a "
Dilutive
              Issuance
"),
              as
              adjusted hereunder (if the holder of the Common Stock or common stock
              equivalents so issued shall at any time, whether by operation of
3
purchase
              price adjustments, reset provisions, floating conversion, exercise
              or exchange
              prices or otherwise, or due to warrants, options or rights per share
              which is
              issued in connection with such issuance, be entitled to receive shares
              of Common
              Stock at an effective price per share which is less than the Conversion
              Price,
              such issuance shall be deemed to have occurred for less than the Conversion
              Price), then, the Conversion Price shall be reduced by multiplying
              the
              Conversion Price by a fraction, the numerator of which is the number
              of shares
              of Common Stock issued and outstanding immediately prior to the Dilutive
              Issuance plus the number of shares of Common Stock and common stock
              equivalents
              which the aggregate consideration received or receivable by the Company
              in
              connection with such Dilutive Issuance would purchase at the then effective
              Conversion Price, and the denominator of which shall be the sum of
              the number of
              shares of Common Stock issued and outstanding immediately prior to
              the Dilutive
              Issuance plus the number of shares of Common Stock and common stock
              equivalents
              so issued or assumable in connection with the Dilutive Issuance.
A
              copy of the Articles of Amendment to the Articles of Incorporation,
              as filed
              with the Secretary of State of the State of Florida, is attached as
              Exhibit 3.1
              to this Current Report on Form 8-K, and is incorporated herein by reference.
Item
            9.01
Financial
            Statements and Exhibits
(c)
Exhibits.
3.1
Articles
                  of Amendment to Articles of Incorporation of Xenomics,
                  Inc.
4.1
Form
                  of Warrant to purchase shares of Common Stock issued in connection
                  with
                  the sale of the Series A Convertible Preferred Stock.
4.2
Form
                  of Warrant to purchase shares of Common Stock issued to selling
                  agents in
                  connection with the sale of the Series A Convertible Preferred
                  Stock.
10.1
Form
                  of Securities Purchase Agreement dated July 13, 2005 by and among
                  Xenomics, Inc. and the purchasers set forth on the signature page
                  thereto.
10.2
Form
                  of Registration Rights Agreement dated July 13, 2005 by and among
                  Xenomics, Inc. and the purchasers signatory thereto.
99.1
Press
                  Release dated July 15, 2005.
4
SIGNATURE
Pursuant
      to the requirements of the Securities Exchange Act of 1934, the Registrant
      has
      duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized.
Dated:
July
      19, 2005
XENOMICS,
              INC.
By:
/s/
              V. Randy White
V.
                Randy White, Ph.D.
Chief
                Executive Officer
5